| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Regenerative Medicine, Osaka University Graduate School of Medicine, Osaka, Japan;
Animal Engineering Research Institute (AERI), Ibaraki, Japan;
Department of Medical Electronics, Suzuka University of Medical Science, Suzuka, Japan; and
Department of Internal Medicine, Seoul National University College of Medicine, and
¶
Xenotransplantation Research Center, Seoul National University Hospital, Seoul, Korea
NK cells play a critical role in the rejection of xenografts. In this study, we report on an investigation of the effect of complement regulatory protein, a decay accelerating factor (DAF: CD55), in particular, on NK cell-mediated cytolysis. Amelioration of human NK cell-mediated pig endothelial cell (PEC) and pig fibroblast cell lyses by various deletion mutants and point substitutions of DAF was tested, and compared with their complement regulatory function. Although wild-type DAF and the delta-short consensus repeat (SCR) 1-DAF showed clear inhibition of both complement-mediated and NK-mediated PEC lyses, delta-SCR2-DAF and delta-SCR3-DAF failed to suppress either process. However, delta-SCR4-DAF showed a clear complement regulatory effect, but had no effect on NK cells. Conversely, the point substitution of DAF (L147·F148 to SS and KKK125–127 to TTT) was half down-regulated in complement inhibitory function, but the inhibition of NK-mediated PEC lysis remained unchanged. Other complement regulatory proteins, such as the cell membrane-bound form factor H, fH-PI, and C1-inactivator, C1-INH-PI, and CD59 were also assessed, but no suppressive effect on NK cell-mediated PEC lysis was found. These data suggest, for DAF to function on NK cells, SCR2–4 is required but no relation to its complement regulatory function exists.
This article has been cited by other articles:
|
|
 |
|
  K. Matsunami, E. Okura, H. Uchida, H. Otsuka, M. Fukuzawa, and S. Miyagawa Identification of Amino Acid Positions Involved in HLA-E Expression J. Biochem., May 1, 2008; 143(5): 641 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jiang, B. A. Orr, D. M. Kranz, and D. J. Shapiro Estrogen Induction of the Granzyme B Inhibitor, Proteinase Inhibitor 9, Protects Cells against Apoptosis Mediated by Cytotoxic T Lymphocytes and Natural Killer Cells Endocrinology, March 1, 2006; 147(3): 1419 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Omidvar, E. C. Y. Wang, P. Brennan, M. P. Longhi, R. A. G. Smith, and B. P. Morgan Expression of Glycosylphosphatidylinositol-Anchored CD59 on Target Cells Enhances Human NK Cell-Mediated Cytotoxicity. J. Immunol., March 1, 2006; 176(5): 2915 - 2923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P.-L. Lee, E. Mansfield, S.-C. Hsieh, T. Hernandez-Boussard, W. Chen, C. W. Thomson, M. S. Ford, S. E. Bosinger, S. Der, Z.-x. Zhang, et al. Expression Profiling of Murine Double-Negative Regulatory T Cells Suggest Mechanisms for Prolonged Cardiac Allograft Survival J. Immunol., April 15, 2005; 174(8): 4535 - 4544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Miyagawa, S. Nakatsu, T. Nakagawa, A. Kondo, K. Matsunami, K. Hazama, J. Yamada, K. Tomonaga, T. Miyazawa, and R. Shirakura Prevention of PERV Infections in Pig to Human Xenotransplantation by the RNA Interference Silences Gene J. Biochem., April 1, 2005; 137(4): 503 - 508. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
